VERIFY Trial: Rusfertide for Polycythemia Vera Patients ASH 3 Mins Read By Srdan Verstovsek, MD, PhD The VERIFY trial polycythemia vera study examines Rusfertide (PTG-300), a hepcidin mimetic, for patients with…
VERIFY Trial PV: ASH 2022 Phase 3 Study on PTG-300 Srdan Verstovsek Hematologic Malignancies 11 Mins Read VERIFY Trial PV: ASH 2022 Phase 3 Study on PTG-300 Srdan Verstovsek By Srdan Verstovsek, MD, PhD How will the…
